1. Home
  2. SKYX vs IVA Comparison

SKYX vs IVA Comparison

Compare SKYX & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYX
  • IVA
  • Stock Information
  • Founded
  • SKYX 2004
  • IVA 2011
  • Country
  • SKYX United States
  • IVA France
  • Employees
  • SKYX N/A
  • IVA N/A
  • Industry
  • SKYX Building Products
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYX Consumer Discretionary
  • IVA Health Care
  • Exchange
  • SKYX Nasdaq
  • IVA Nasdaq
  • Market Cap
  • SKYX 135.1M
  • IVA 117.3M
  • IPO Year
  • SKYX 2022
  • IVA 2020
  • Fundamental
  • Price
  • SKYX $1.07
  • IVA $2.28
  • Analyst Decision
  • SKYX Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • SKYX 3
  • IVA 4
  • Target Price
  • SKYX $4.00
  • IVA $13.25
  • AVG Volume (30 Days)
  • SKYX 323.3K
  • IVA 9.1K
  • Earning Date
  • SKYX 11-12-2024
  • IVA 09-25-2024
  • Dividend Yield
  • SKYX N/A
  • IVA N/A
  • EPS Growth
  • SKYX N/A
  • IVA N/A
  • EPS
  • SKYX N/A
  • IVA N/A
  • Revenue
  • SKYX $84,766,991.00
  • IVA $20,652,523.00
  • Revenue This Year
  • SKYX $57.86
  • IVA N/A
  • Revenue Next Year
  • SKYX $41.24
  • IVA $361.78
  • P/E Ratio
  • SKYX N/A
  • IVA N/A
  • Revenue Growth
  • SKYX 131.47
  • IVA N/A
  • 52 Week Low
  • SKYX $0.72
  • IVA $1.53
  • 52 Week High
  • SKYX $1.87
  • IVA $4.75
  • Technical
  • Relative Strength Index (RSI)
  • SKYX 45.60
  • IVA 27.94
  • Support Level
  • SKYX $1.00
  • IVA $2.52
  • Resistance Level
  • SKYX $1.16
  • IVA $2.65
  • Average True Range (ATR)
  • SKYX 0.09
  • IVA 0.11
  • MACD
  • SKYX 0.00
  • IVA -0.04
  • Stochastic Oscillator
  • SKYX 28.57
  • IVA 0.00

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. The company's technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post and is capable of feeding electric power to an appliance. The Company generates its income from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: